MAY 06, 2020 8:19 AM PDT

Breakthrough in Antibody Treatment for COVID-19

WRITTEN BY: Annie Lennon

Israeli scientists have announced significant progress in isolating an antibody that may be effective in treating those with coronavirus. Although not yet tested on animals nor humans, it shows signs of being able to neutralize the virus in humans. 

From research conducted by the Israel Institute of Biological Research, the antibody seems to meet three key parameters for treating the virus. Firstly, it is monoclonal. This means that it does not contain antibodies that would render it difficult to use. Next, tests have shown that the antibody is able to neutralize the virus. Lastly, the scientists showed that at least in a petri dish, the antibody is able to treat an aggressive strain of the virus. 

As far as we know, according to comprehensive scientific publication from around the world, the Biological Research Institute is the first in the world to achieve this breakthrough in these three parameters at the same time.” say the researchers. 

Although exact timelines are not yet known, the researchers will next test the antibody in animals, and then humans. Meanwhile, Professor Shumel Shapiro, the institute’s director said that the antibody is in the process of receiving a patent, and that the next phase of research includes contacting manufacturers around the world to put the antibody in mass production for commercial use. 

Given that close to 4 million people around the world have contracted the virus, with around 260,000 dead as of May 6 2020, many are optimistic on what this finding could mean for the future of the disease. 

Having called their finding a ‘significant breakthrough’, the researchers nevertheless warn that the treatment must still be confirmed in experimental settings and that a treatment made with the antibody will take time. 

“This is an important milestone, but afterwards comes complicated tests and a process of getting regulatory approval.” said the Biological Research Institute in a statement. “Per an assessment by the institute’s scientists, this technological breakthrough is poised to shorten the process, which will go on for several months.”


Sources: Forbes, Business Insider

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUL 11, 2021
Drug Discovery & Development
Antibiotic Resistance May Be Passed Between Dogs and Owners
JUL 11, 2021
Antibiotic Resistance May Be Passed Between Dogs and Owners
Household pets may act as a reservoir for mcr-1, a gene that is resistant to a last-resort antibiotic, colistin. The fin ...
JUL 12, 2021
Drug Discovery & Development
Testosterone Supplements Reduce Heart Attack and Stroke Risk
JUL 12, 2021
Testosterone Supplements Reduce Heart Attack and Stroke Risk
Taking testosterone supplements significantly reduces risk of heart attack and stroke among men with low levels of the h ...
JUL 27, 2021
Drug Discovery & Development
Immune related genes influence antipsychotic-induced weight gain.
JUL 27, 2021
Immune related genes influence antipsychotic-induced weight gain.
Mental disorders such as Schizophrenia and Bipolar disorder are currently incurable, but some symptoms can be treated wi ...
JUL 29, 2021
Drug Discovery & Development
What is Ivermectin and Can it Treat COVID?
JUL 29, 2021
What is Ivermectin and Can it Treat COVID?
Lab tests in 2020 found that the widely available drug ivermectin had a weak effect on the SARS-CoV-2 virus and that unf ...
AUG 08, 2021
Drug Discovery & Development
Dietary Supplements Treat Genetic Cause of PTSD
AUG 08, 2021
Dietary Supplements Treat Genetic Cause of PTSD
A combination of two natural nutritional supplements, vitamin A and methyl donor S-adenosylmethionine (SAM), can treat P ...
SEP 16, 2021
Drug Discovery & Development
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
SEP 16, 2021
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
According to the Population Reference Bureau, 40 million people in the United States are aged 65 and older. This nu ...
Loading Comments...